ZO Skin Health Reformulates Rozatrol

ZO Skin Health has unveiled a reformulated version of Rozatrol, its signature serum for red, sensitive and rosacea-prone skin. The updated product, launching in May 2025, introduces a new proprietary complex designed to deliver improved relief from redness while strengthening the skin barrier and supporting the microbiome.

The newly reformulated Rozatrol now includes ZPOLY, an exclusive plant-derived polysaccharide complex developed by ZO to accelerate barrier repair and extend hydration. This addition works alongside the brand’s existing ZO-RRS2 antioxidant stem cell blend and a new microbiome-balancing blend to deliver visible soothing and long-term skin health benefits.

Positioned as an expert solution for those with rosacea-prone or reactive skin, Rozatrol’s reformulated formula is clinically backed. In an independent 6-week study, 82% of participants reported visibly soothed and calmed skin. 73% noted a reduction in redness and a visible improvement in flushing and blood vessel visibility with continued use.

Key actives include lactose, milk protein, and broccoli extract, which work to reduce sensitivity and support a more uniform complexion.

The serum is designed for twice-daily application and is available exclusively through authorised ZO Skin Health clinics and stockists.